Home News General Health News ACC: New Guidelines Issued for Primary Prevention of CVD

ACC: New Guidelines Issued for Primary Prevention of CVD

Guidelines emphasize promotion of healthy lifestyle, including healthy diet, exercise, weight loss

FRIDAY, March 22, 2019 (HealthDay News) — Recommendations have been developed for primary prevention of atherosclerotic cardiovascular disease (ASCVD); the American College of Cardiology/American Heart Association guideline was published online March 17 in Circulation to coincide with presentation at the annual meeting of the American College of Cardiology, held from March 16 to 18 in New Orleans.

Donna K. Arnett, Ph.D., from the University of Kentucky College of Public Health in Lexington, and colleagues consolidated existing recommendations and other evidence into a single guidance document on the primary prevention of ASCVD.

The authors note that promotion of a healthy lifestyle throughout life is the most important way to prevent atherosclerotic vascular disease, heart failure, and atrial fibrillation. The most effective strategy for prevention of cardiovascular disease is a team-based care approach. Ten-year ASCVD risk estimation should be performed for adults aged 40 to 75 years who are being evaluated for cardiovascular disease prevention. All adults should consume a healthy diet emphasizing vegetable, fruit, nut, whole grain, lean vegetable or animal protein, and fish intake and minimizing intake of trans fats, processed meat, refined carbohydrates, and sweetened beverages. Counseling and caloric restriction are recommended for achieving and maintaining weight loss for adults with overweight and obesity. At least 150 minutes per week of accumulated moderate-intensity physical activity or 75 minutes per week of vigorous-intensity physical activity is recommended for adults. Lifestyle changes are crucial for adults with type 2 diabetes mellitus.

“We can all do better with our dietary and exercise habits, and that’s so important when we think about wanting to live longer and healthier lives,” a coauthor said in a statement.

Several reviewers disclosed financial ties to the pharmaceutical and medical technology industries.

Abstract/Full Text (subscription or payment may be required)

Editorial (subscription or payment may be required)

More Information

Copyright © 2019 HealthDay. All rights reserved.